Intracellular iron supplementation selectively sensitizes cancer cells to high-dose VC by disrupting the oxidative metabolism, and we consider that 68Ga-citrate PET imaging may be able to screen out tumor patients with high TFR expression, which could be more sensitive to VC treatment combined with iron supplementation. This evidence concerns the gene TFRC and neoplasm.